As long as they can operate Eve’s remote, eligible adults with spinal cord injuries at any level can walk and perform activities of daily living hands-free using self-balancing technology. The device is intended for use on level indoor surfaces and level surfaces in immediately adjacent open-air areas that are part of a building, such as patios and terraces, under the supervision of a specially trained companion. 

“FDA clearance of Eve marks one of the most important moments in Wandercraft’s history and a significant step for the people, families, clinicians, researchers and partners who helped make it possible,” Matthieu Masselin, co-founder and CEO of Wandercraft, said in a press release.